OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetics of Alzheimer’s Disease
Vincent Chouraki, Sudha Seshadri
Advances in genetics (2014), pp. 245-294
Closed Access | Times Cited: 196

Showing 26-50 of 196 citing articles:

Alzheimer disease
Ana Laura Calderón‐Garcidueñas, Charles Duyckaerts
Handbook of clinical neurology (2017), pp. 325-337
Closed Access | Times Cited: 106

Redox proteomics and amyloid β‐peptide: insights into Alzheimer disease
D. Allan Butterfield, Debra Boyd‐Kimball
Journal of Neurochemistry (2018) Vol. 151, Iss. 4, pp. 459-487
Open Access | Times Cited: 97

Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
Irene López González, Paula Garcia‐Esparcia, Franc Llorens, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 2, pp. 206-206
Open Access | Times Cited: 94

Role of FET proteins in neurodegenerative disorders
Francesca Svetoni, Paola Frisone, Maria Paola Paronetto
RNA Biology (2016) Vol. 13, Iss. 11, pp. 1089-1102
Open Access | Times Cited: 87

Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene
Jaya Bagaria, Eva Bagyinszky, Seong Soo A. An
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10970-10970
Open Access | Times Cited: 56

Genome-wide association of polygenic risk extremes for Alzheimer's disease in the UK Biobank
Catarina Gouveia, Elizabeth Gibbons, Nadia Dehghani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 47

Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
Degiri Kalana Lasanga Senevirathne, Anns Mahboob, Kevin Zhai, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1478-1478
Open Access | Times Cited: 23

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
Seong Soo A. An, Yan Cai, SangYun Kim
Clinical Interventions in Aging (2015), pp. 1163-1163
Open Access | Times Cited: 90

The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis
Silvia Moncini, Marta Lunghi, Alice Valmadre, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 6, pp. 4329-4342
Closed Access | Times Cited: 84

Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer’s Disease
Juan M. Saavedra
Cellular and Molecular Neurobiology (2016) Vol. 36, Iss. 2, pp. 259-279
Closed Access | Times Cited: 77

Bridging the gap: large animal models in neurodegenerative research
Samantha L. Eaton, Thomas M. Wishart
Mammalian Genome (2017) Vol. 28, Iss. 7-8, pp. 324-337
Open Access | Times Cited: 77

Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Erwin Lemche
Current Genomics (2018) Vol. 19, Iss. 7, pp. 522-602
Open Access | Times Cited: 73

Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes
Ke Hao, Antonio Fabio Di Narzo, Lap Ho, et al.
Molecular Aspects of Medicine (2015) Vol. 43-44, pp. 66-76
Open Access | Times Cited: 72

Innate immune activation in Alzheimer’s disease
Mingming Wang, Dan Miao, Xi‐Peng Cao, et al.
Annals of Translational Medicine (2018) Vol. 6, Iss. 10, pp. 177-177
Open Access | Times Cited: 68

Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine
Zhi-Xu He, Xiao-Wu Chen, Zhi-Wei Zhou, et al.
Drug Metabolism Reviews (2015) Vol. 47, Iss. 4, pp. 470-519
Closed Access | Times Cited: 67

Dance for People with Alzheimer’s Disease: A Systematic Review
Alicia Ruiz‐Muelle, María Mar López‐Rodriguez
Current Alzheimer Research (2019) Vol. 16, Iss. 10, pp. 919-933
Closed Access | Times Cited: 56

“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
Chinthalapally V. Rao, Adam S. Asch, Daniel J.J. Carr, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 55

Discovery and Validation of Key Biomarkers Based on Immune Infiltrates in Alzheimer’s Disease
Zhuohang Liu, Hang Li, Shuyi Pan
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 55

Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
Oneil G. Bhalala, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1231-1231
Open Access | Times Cited: 6

Multisystem Lewy body disease and the other parkinsonian disorders
J. William Langston, Birgitt Schüle, Linda Rees, et al.
Nature Genetics (2015) Vol. 47, Iss. 12, pp. 1378-1384
Closed Access | Times Cited: 59

Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease
Jóhanna Jakobsdóttir, Sven J. van der Lee, Joshua C. Bis, et al.
PLoS Genetics (2016) Vol. 12, Iss. 10, pp. e1006327-e1006327
Open Access | Times Cited: 57

Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases
Lary C. Walker
Annual Review of Genetics (2016) Vol. 50, Iss. 1, pp. 329-346
Open Access | Times Cited: 56

Clinical Neurophysiological and Automated EEG-Based Diagnosis of the Alzheimer's Disease
Shreya Bhat, U. Rajendra Acharya, Nahid Dadmehr, et al.
European Neurology (2015) Vol. 74, Iss. 3-4, pp. 202-210
Open Access | Times Cited: 55

Prion-like mechanisms in Alzheimer disease
Lary C. Walker
Handbook of clinical neurology (2018), pp. 303-319
Open Access | Times Cited: 54

Scroll to top